Z-2262-2013 Class II Terminated

Recalled by Maquet Cardiovascular Us Sales, Llc — Wayne, NJ

FDA device recall Z-2262-2013 was initiated by Maquet Cardiovascular Us Sales, Llc on Aug 15, 2013 and is designated Class II. Reason for recall: The manufacturer has conducted a review of the results of product testing performed during the last twelve months and has identified specific lots of product which may not meet specifications for bond… The recall status is terminated (terminated Jul 11, 2017). Affected quantity: 1,182 units.

Recall details

Product Type
Devices
Report Date
Oct 2, 2013
Initiation Date
Aug 15, 2013
Termination Date
Jul 11, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,182 units

Product description

QUADROX iD HMOD 2030 Diffusion Membrane Oxygenator; QUADROX-i ADULT HMO 70000 / HMO 71000; QUADROX-iD Pediatric HMOD 30000. The QUADROX oxygenators are intended for use in extracorporeal circulation during cardiopulmonary bypass in cardiac surgery.

Reason for recall

The manufacturer has conducted a review of the results of product testing performed during the last twelve months and has identified specific lots of product which may not meet specifications for bond strength on the inlet and/or outlet connector.

Distribution pattern

Worldwide Distribution, including Nationwide (US) and foreign countries.

Code information

QUADROX-iD Adult catalog number HMOD 70000, lot # 70081567 QUADROX-i Adult catalog number VKMO 70000, lot # 70082663 QUADROX-i Adult catalog number VKMO 71000, lot # 70083974

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2262-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2262-2013. Report a data issue: hello@regdatalab.com.